5726 - 5750 of 7877 Results
Title
Year
-
OPENTitle: A Marked Point Process Framework for Extracellular Electrical PotentialsJournal Name: Frontiers in Systems NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsys.2017.00095Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnsys.2017.00095/pdfCitation Count: 13
- Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study2017OPENTitle: Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 1Start Page: 64End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(17)30400-3Best OA location URL: http://manuscript.elsevier.com/S1474442217304003/pdf/S1474442217304003.pdfCitation Count: 209
-
RESTRICTEDTitle: Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer's diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 285Issue #: 6Start Page: 995End Page: 1011Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/febs.14332Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.14332Citation Count: 188
-
RESTRICTEDTitle: Neurodegeneration: Keeping ATF4 on a Tight LeashJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2017.00410Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2017.00410/pdfCitation Count: 56
- Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness2017OPENTitle: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepinessJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 43Issue #:Start Page: 25End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2017.11.1137Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/83291977/Increased_dopaminergic_function_in_YOUSAF_Firstonline12December2017_GREEN_AAM_CC_BY_NC_ND_.pdfCitation Count: 13
-
RESTRICTEDTitle: Crosstalk between Lysosomes and Mitochondria in Parkinson's DiseaseJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2017.00110Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2017.00110/pdfCitation Count: 77
- Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons2017OPENTitle: Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 111Issue #:Start Page: 26End Page: 35Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.12.005Best OA location URL: https://europepmc.org/articles/pmc5803451?pdf=renderCitation Count: 111
-
RESTRICTEDTitle: iPS cells in the study of PD molecular pathogenesisJournal Name: Cell and Tissue ResearchPublisher: Springer Science and Business Media LLCVol: 373Issue #: 1Start Page: 61End Page: 77Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00441-017-2749-yBest OA location URL: https://europepmc.org/articles/pmc5997490?pdf=renderCitation Count: 30
-
OPENTitle: Associations Between Tau, β-Amyloid, and Cognition in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 75Issue #: 2Start Page: 227End Page: 227Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2017.3713Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2664949/jamaneurology_winer_2017_oi_170089.pdfCitation Count: 58
- The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK12017OPENTitle: The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1Journal Name: ChemBioChemPublisher: WileyVol: 19Issue #: 5Start Page: 425End Page: 429Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/cbic.201700500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cbic.201700500Citation Count: 48
- Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort2017OPENTitle: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 47Issue #:Start Page: 3End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006Best OA location URL: https://europepmc.org/articles/pmc5803409?pdf=renderCitation Count: 44
-
OPENTitle: Rab29 activation of the Parkinson's disease‐associated LRRK2 kinaseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 37Issue #: 1Start Page: 1End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.201798099Best OA location URL: https://doi.org/10.15252/embj.201798099Citation Count: 308
- Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term2017OPENTitle: Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long termJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 135Issue #: 1Start Page: 65End Page: 83Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-017-1792-9Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00401-017-1792-9.pdfCitation Count: 168
- Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features2017OPENTitle: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease FeaturesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 282End Page: 288Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27232Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27232Citation Count: 127
- Failure of Sequential Pallidal and Motor Thalamus DBS for Rapid‐Onset Dystonia‐Parkinsonism (DYT12)2017OPENTitle: Failure of Sequential Pallidal and Motor Thalamus DBS for Rapid‐Onset Dystonia‐Parkinsonism (DYT12)Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 444End Page: 445Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12559Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12559Citation Count: 10
-
RESTRICTEDTitle: Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 236End Page: 245Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.07.019Best OA location URL: https://doi.org/10.1016/j.expneurol.2017.07.019Citation Count: 128
-
RESTRICTEDTitle: Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 202End Page: 209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.08.001Best OA location URL: https://europepmc.org/articles/pmc6037988?pdf=renderCitation Count: 74
- Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trial2017OPENTitle: Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trialJournal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e017194End Page: e017194Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-017194Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e017194.full.pdfCitation Count: 31
-
OPENTitle: Neurogenic dysphagia with undigested macaroni and megaesophagus in familial dysautonomiaJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 28Issue #: 1Start Page: 125End Page: 126Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-017-0487-6Best OA location URL: https://europepmc.org/articles/pmc5807189?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 137End Page: 147Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.001Citation Count: 50
- Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomalironimagingin Parkinson’s disease)2017OPENTitle: Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomalironimagingin Parkinson’s disease)Journal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e016904End Page: e016904Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-016904Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e016904.full.pdfCitation Count: 6
-
RESTRICTEDTitle: Targeting urate to reduce oxidative stress in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 210End Page: 224Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.06.017Best OA location URL: http://manuscript.elsevier.com/S0014488617301577/pdf/S0014488617301577.pdfCitation Count: 103
-
RESTRICTEDTitle: Therapeutic approaches to target alpha-synuclein pathologyJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 225End Page: 235Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.003Best OA location URL: http://manuscript.elsevier.com/S0014488617302455/pdf/S0014488617302455.pdfCitation Count: 192
- A proteomic network approach across the ALS ‐ FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain2017OPENTitle: A proteomic network approach across the ALS ‐ FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brainJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 48End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201708202Best OA location URL: https://doi.org/10.15252/emmm.201708202Citation Count: 136
- Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation2017OPENTitle: Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin DownregulationJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 9Issue #: 6Start Page: 1853End Page: 1867Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2017.10.029Best OA location URL: http://www.cell.com/article/S2213671117304848/pdfCitation Count: 44